SCHEDULE 13G: Alyeska Investment Group Discloses 9.61% Stake in Outset Medical, Inc.

Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, has disclosed a 9.61% beneficial ownership stake in Outset Medical, Inc., totaling 1,703,083 shares of common stock.

Summary

• Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh collectively reported beneficial ownership of 1,703,083 shares of Outset Medical, Inc. common stock.
• This ownership represents 9.61% of the company's outstanding common stock.
• The percentage calculation is based on 17,722,035 outstanding shares of Common Stock, as reported in Outset Medical's Form DEF 14A filed with the SEC on April 11, 2025.
• The reporting persons hold shared voting power and shared dispositive power over all 1,703,083 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Outset Medical, Inc.

Sentiment

Score: 6

Explanation: The document is a factual regulatory filing disclosing a significant ownership stake by an institutional investor. While the disclosure of a substantial stake by Alyeska Investment Group could be interpreted as a positive signal of investor confidence, the filing itself is neutral in tone and does not contain performance data or forward-looking statements from the issuer.

Positives

• A significant institutional investor, Alyeska Investment Group, L.P., has disclosed a substantial 9.61% stake in Outset Medical, Inc., which could be interpreted as a signal of investor confidence in the company.

Future Outlook

This Schedule 13G filing does not contain forward-looking statements or guidance regarding Outset Medical, Inc.'s future outlook.

Industry Context

This filing is a standard ownership disclosure and does not provide specific industry context or trends related to Outset Medical, Inc. beyond identifying it as a publicly traded company in the medical sector.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant institutional ownership. The disclosure of a substantial stake by a prominent investment group may positively influence investor sentiment.

Key Dates

Keywords

Outset Medical, Alyeska Investment Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Medical Devices, Healthcare Technology